Sorting nexin 9 (SNX9) belongs to a family of proteins, the sorting nexins, that are characterized by the presence of a subclass of the phosphoinositide-binding phox domain. SNX9 has in its amino terminus a Src homology 3 domain and a region with predicted low complexity followed by a carboxyl-terminal part containing the phox domain. We previously found that SNX9 is one of the major proteins in hematopoietic cells that binds to the ␣-and ␤2-appendages of adaptor protein complex 2 (AP-2), a protein with a critical role in the formation of clathrin-coated vesicles at the plasma membrane. In the present study we show that clathrin and dynamin-2, two other essential molecules in the endocytic process, also interact with SNX9. We found that both AP-2 and clathrin bind to the low complexity region in SNX9 in a cooperative manner, whereas dynamin-2 binds to the Src homology 3 domain. In the cytosol, SNX9 is present in a 14.5 S complex containing dynamin-2 and an unidentified 41-kDa protein. In HeLa cells, SNX9 co-localized with both AP-2 and dynamin-2 at the plasma membrane or on vesicular structures derived from it but not with the early endosomal marker EEA1 or with AP-1. The results suggest that SNX9 may be recruited together with dynamin-2 and become co-assembled with AP-2 and clathrin at the plasma membrane. Overexpression in both K562 and HeLa cells of truncated forms of SNX9 interfered with the uptake of transferrin, consistent with a role of SNX9 in endocytosis.
The family name sorting nexin (SNX) 1 is given to a large group of proteins that are represented throughout the eukaryotic kingdom. Sorting nexins are characterized by the presence of a subclass of the phosphoinositide-binding phox (PX) domain, and it is believed that a common function of proteins in this family is to participate in sorting processes in the cell. Several members localize to endosomal structures, and some of the SNX proteins have been shown to directly interact with transmembrane receptors to regulate their sorting in the endosomal pathway (for a review, see Ref. 1) . The localization of SNX proteins is suggested to be determined by their PX domains, although protein-protein interactions may also contribute to the membrane specificity (2, 3) .
SNX9 and its close relative SNX18 are the only members of the sorting nexin family that contains an Src homology 3 (SH3) domain. SH3 domains interact specifically with short prolinecontaining sequences (PXXP) and are present in a large number of proteins (4) . Target sequences are often located in distinct domains, referred to as proline-rich domains (PRDs). SNX9 was originally identified as a molecule that interacted with PRDs in certain metalloprotease disintegrins (ADAMs) (5) . Work in Drosophila showed that SNX9 (named DSH3PX1) interacted with Dock (the fly orthologue of mammalian Nck) and Dscam (Down's syndrome cell adhesion molecule) to form a complex involved in axonal guidance in the fly (6, 7) . In addition, SNX9 was found to interact with the clathrin-binding tyrosine kinase Ack through an SH3-PRD interaction. In mammalian cells, Ack2 interacted with the receptor for epidermal growth factor, and this interaction was stabilized by SNX9. Upon stimulation with epidermal growth factor, SNX9 became tyrosine-phosphorylated and was suggested to play a role together with Ack2 in the degradation of the epidermal growth factor receptor (8) .
In a previous report (9) , we identified SNX9 as one of the major proteins in the cytosol from human K562 cells that bound to the appendages of adaptor protein complex 2 (AP-2). It was therefore suggested that SNX9 in some way is involved in the process of clathrin-coated vesicle formation at the plasma membrane. Clathrin-mediated endocytosis is triggered by the assembly of AP-2 and clathrin at specific sites at the plasma membrane, mediated by interactions with phosphoinositides in the membrane (10 -12) . As the clathrin coat forms, the membrane invaginates and becomes a coated pit. Once activated in the coat, AP-2 reaches out to collect transmembrane cargo proteins by protein-protein interactions (13) . A variety of accessory factors participates in these events, many of them interacting with the appendage domains of AP-2 (14) . At a certain stage, the large GTPase dynamin is recruited to the coated pit and forms a collar at its base (15, 16) . The assembly of dynamin leads to fission of the clathrin-coated vesicle from the membrane, possibly by a force generated through the hydrolysis of GTP. Although it is known that dynamin plays an essential role in the later stages of endocytosis, the mechanism of action has not yet been revealed (17, 18) . In addition, it has not been established how this important molecule is targeted to the membrane. In the present study, we identify dynamin-2 (Dyn2) as a major partner for SNX9 in the cytosol from hematopoietic cells and show that SNX9 assembles with Dyn2 and AP-2 at the plasma membrane. The results suggest that SNX9 plays a role in the clathrin-dependent endocytic machinery.
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EXPERIMENTAL PROCEDURES
Antibodies-Polyclonal antiserum against SNX9 was generated by immunizing a rabbit with glutathione S-transferase (GST)-SNX9 fusion protein. Antibodies were affinity-purified using the recombinant protein or used as serum after removal of anti-GST antibodies. Purchased antibodies were: mouse anti-EEA1 clone 14 (BD Transduction Laboratories, Lexington, KY), mouse anti-␤1/␤2-adaptin clone 100/1, mouse anti-FLAG (Sigma), rabbit anti-dynamin-2 (Affinity Bioreagents, Golden, CO), mouse anti-dynamin Hudy 1 (Upstate Biotechnology, Waltham, MA), fluorescein-linked donkey anti-rabbit immunoglobulins, and Cy3-linked goat anti-mouse immunoglobulins (Amersham Biosciences). All other antibodies were as described previously (9) .
DNA Constructs-cDNAs encoding human full-length SNX9, SH3, LC, LC-2, LC-3, and LC-4 were amplified by PCR using the appropriate primers and IMAGE clone 3832234 (UK Human Genome Mapping Project Resource Centre) as template. After digestion, the PCR products were ligated into the pGEX-5X-1 or pGEX-6p-2 vector (Amersham Biosciences) generating GST fusion constructs. Coding regions corresponding to SH3LC, PXCT, LC-1, and SH3LCPX were excised from fulllength SNX9 or from the LC construct and subcloned into the pGEX-5X-1 or pGEX-6p-2 vector. GST-LC-108S (W108S substitution), GST-LC-165S/169S (W165S,W169S substitutions), and GST-LC108S/165S/ 169S (W108S,W165S,W169S substitutions) were created by PCRdirected mutagenesis using the QuikChange kit (Stratagene, La Jolla, CA). GST-␣ c and GST-␤3 c were described before (9) . The construct encoding human dynamin-2 PRD (19) was a kind gift from Dr. Peter Westermann.
For expression in K562 cells, DNA encoding SNX9 and SH3LCPX was excised from IMAGE clone 3832234 and inserted into the expression vector pMEP4 (Invitrogen). To obtain amino-terminal FLAGtagged proteins, oligonucleotides corresponding to a FLAG peptide (DYKDDDDK) were inserted into the pMEP4 vector. DNA encoding SNX9, SH3LC, and PXCT were then subcloned into the modified vector. For expression in HeLa cells, FLAG-SNX9 and FLAG-SH3LC was excised from the pMEP4-FLAG vector and inserted into the pFLAG-CMV-4 vector (Sigma). All constructs and mutations were confirmed by sequencing. All oligonucleotides were purchased from DNA Technologies (Aarhus, Denmark).
Transfections-The conditions for transfection of K562 cells by electroporation were as described previously (20) . Induction of expression by 0.1-0.5 M Cd 2ϩ resulted in a 10 -15-fold expression over endogenous SNX9 as estimated by immunoblotting. HeLa cells grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 2 mM glutamine, and antibiotics were transfected using the CaCl 2 method (21) .
Immunofluorescence and Transferrin Uptake-HeLa cells grown on coverslips were fixed in 2% paraformaldehyde in phosphate-buffered saline for 20 min on ice, washed, and permeabilized and blocked in 0.05% saponin, 1% bovine serum albumin in phosphate-buffered saline. Cells were stained with the appropriate primary and secondary antibodies following standard protocols and scanned with a laser scanning Leica DMIRBE confocal microscope equipped with an argon-krypton laser. Sets of fluorescent images were acquired sequentially for the red and green channels to prevent crossover of signals. To quantify the degree of co-localization, cells were divided into 100-m 2 squares, and the total number of red, green, and yellow fluorescent dots was counted in each square. In total 14 squares and over 800 dots from several cells were counted for each quantification, and the percent co-localization was calculated.
Holotransferrin (Calbiochem) was biotinylated by a 7-fold molar excess of sulfo-N-hydroxysuccinimide-SS-biotin (Pierce) in 50 mM NaHCO 3 and desalted. For transferrin uptake experiments, transfected cells were harvested, starved in serum-free medium for 30 min at 37°C, and incubated for 15 min at 37°C with serum-free medium supplemented with 25 g/ml biotinylated transferrin. Cells were washed repeatedly in phosphate-buffered saline to remove surface-bound transferrin before fixation. After washes, cells were opened and blocked as indicated above before incubation with primary and secondary antibodies and Cy3-labeled streptavidin (Amersham Biosciences). After repeated washes, cells were mounted and viewed using a Carl Zeiss Axioplan microscope. Analysis of transferrin uptake by enzyme-linked immunosorbent assay was performed essentially as described before (22) using glutathione for quenching of surface-bound transferrin.
Protein Expression and Purification-GST fusion proteins were expressed in Escherichia coli and purified as described previously (9) . Dynamin PRD was expressed and purified according to Ref. 19 . GST-␣ c was cleaved overnight at 37°C with Factor Xa (Amersham Biosciences) according to the manufacturer's instructions followed by repeated absorption with glutathione-Sepharose beads.
For purification of clathrin triskelions, cytosol was incubated with glutathione-Sepharose to which GST-␤3 c was previously cross-linked using dimethyl pimelimidate (Sigma). After extensive washes of the beads in 0.1% Triton X-100 in HKM buffer (100 mM potassium acetate, 20 mM HEPES-KOH, and 1 mM magnesium acetate, pH 7.4) bound material was eluted with 0.5 M Tris-HCl, pH 7.5. Before use in binding experiments, the buffer was changed to HKM buffer using MicroBioSpin P6 columns (Bio-Rad).
Preparation and Use of Cytosol-K562 cells were harvested and washed twice in phosphate-buffered saline and twice in KSHM buffer (HKM buffer with 85 mM sucrose), both supplemented with 0.5 mM sodium orthovanadate. Cells were resuspended with 1-2 volumes of KSHM buffer containing 1 mM sodium orthovanadate and a protease inhibitor mixture (9) , and the suspension was rapidly frozen in liquid nitrogen. After thawing, the cells were pelleted by centrifugation at 850 ϫ g for 5 min. The morphology of the cells was not affected by this treatment indicating that internal structures were mainly intact. The majority of both SNX9 and Dyn2 was released into the supernatant. The supernatant was centrifuged at 70,000 ϫ g for 30 min, and the cytosol was aliquoted and stored at Ϫ80°C. The protein concentration was 15-20 mg/ml. The cytosol was thawed and centrifuged for 10 min at 20,000 ϫ g before use.
For immunoprecipitations, cytosol was added to protein A-Sepharose beads (Amersham Biosciences) to which antibodies were previously bound, and the samples were incubated by slow agitation for 1-3 h at 4°C. Beads were washed three times in 0.5% Nonidet P-40 in 20 mM HEPES-KOH, pH 7.4 before analysis by SDS-PAGE combined with immunoblotting or Coomassie Blue staining. Pull-down assays with GST fusion proteins were performed as described before (9) . For pulldown assays with purified proteins, equal molar amounts of fusion proteins (3 M) were used together with 8 M Dyn2-PRD, 3 M AP-2 ␣-appendage, or 0.2 M clathrin heavy chain.
For velocity sedimentation analysis, freshly prepared cytosol (250 l) was loaded on top of a 4-ml continuous sucrose gradient (10 -30% sucrose in 20 mM HEPES-KOH, 1 mM magnesium acetate, 1 mM sodium orthovanadate, pH 7.4) and centrifuged at 4°C in a Beckman SW60 rotor at 200,000 ϫ g av for 16 h. In parallel, a mixture of bovine serum albumin, catalase, and ferritin as sedimentation markers was centrifuged. Fractions (250 l) were collected from the top. A pellet fraction was obtained by resuspension in 250 l of 20 mM HEPES-KOH, pH 7.4.
Membrane Analysis-A 70,000 ϫ g pellet fraction obtained from the cytosol preparation (see above) containing membranes and vesicles was resuspended in 1% Nonidet P-40 in KSHM buffer and incubated for 20 min on ice and centrifuged at 70,000 ϫ g for 30 min. The supernatant was collected and analyzed, and the pellet was divided in two aliquots that were either incubated in a low salt buffer (85 mM sucrose, 20 mM HEPES-KOH, and 1 mM magnesium acetate, pH 7.4) or in an equal mixture of 1 M Tris-HCl, pH 7.4 and KSHM buffer. After incubation on ice for 20 min, the samples were centrifuged at 70,000 ϫ g for 30 min, and the supernatants were analyzed. The pellets contained less than 1% of the total protein in the starting material and were found to be devoid of clathrin, AP-2, Dyn2, and SNX9.
Membrane/vesicular material obtained after freezing/thawing of K562 cells as above were separated according to density by equilibrium centrifugation in a 12-ml continuous 0 -60% Nycodenz gradient in KSHM buffer. After centrifugation in an SW41 rotor at 40,000 rpm for 16 h, fractions (1 ml) were collected from the top and analyzed by SDS-PAGE and immunoblotting and for density by refractometry. A pellet fraction was obtained by resuspension in 1 ml of KSHM buffer.
Protein Identification by Mass Spectrometry-Coomassie Bluestained bands from SDS-PAGE were excised, and proteins were digested with 1 g of trypsin (sequencing grade modified trypsin, Promega, Madison, WI) and analyzed on a Voyager DE-STR MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA) essentially as described before (23) . Peptide coverage was Ͼ50% for both dynamin-2 and clathrin heavy chain.
Liposome Experiments-Phospholipids were purchased from Matreya (State College, PA) or from Sigma. Liposomes (50 nmol of phospholipid/ reaction) were prepared in KSHM buffer essentially as described before (24) and incubated with GST fusion proteins in a total volume of 40 l of KSHM buffer containing 0.5 mg/ml bovine serum albumin. After incubation on ice for 15 min, the liposomes were pelleted by centrifugation at 20,000 ϫ g for 5 min. Liposomes were rinsed with 200 l of KSHM buffer, centrifuged, and finally prepared for SDS-PAGE.
RESULTS

Identification of Proteins
Interacting with SNX9 -We previously described that SNX9 contains binding sites for the appendages of AP-2 (9). Since SNX9 consists of several domains with potential binding function, it was of interest to identify other interacting endocytic proteins to establish a role for SNX9 in this system and to map the interaction sites in SNX9. Full-length SNX9 and truncation variants were produced as GST fusion proteins and used in binding experiments and for the production of polyclonal antibodies. Fig. 1 shows the constructs and the nomenclature used in the present investigation. In a pull-down experiment from cytosol, several proteins were detected that specifically interacted with the GST fusion proteins ( Fig. 2A) . Two of the major binding proteins, migrating at 180 and 110 kDa, were identified by mass spectrometry as clathrin heavy chain and Dyn2, respectively ( Fig. 2A, bands  denoted 1 and 2) . Both of these proteins were pulled down by the amino-terminal one-third of SNX9 (GST-SH3LC).
To identify more precisely the domains in SNX9 that bound clathrin, Dyn2, and AP-2, pull-down experiments were performed with fusion proteins containing different parts of SNX9 together with both cytosol and purified proteins. Fig. 2B shows that the SH3 domain in SNX9 binds directly to the PRD in Dyn2. This result was expected since several other SH3-containing proteins interact with dynamin through this region (16) . Both clathrin and AP-2 ␣-appendage bind to a disordered region (designated LC) located between the SH3 and PX domains. The binding of the ␣-appendage was stronger to the SH3LC construct than to full-length SNX9, and clathrin-binding was only detectable with the SH3LC construct (see also Fig.  2A) , suggesting that the binding sites for clathrin and AP-2 is obstructed in full-length SNX9. The low complexity sequence between the SH3 and PX domains that is located outside the LC region (starting at amino acid 185) does not appear to possess any strong binding sites for clathrin and AP-2 ␣-chain since construct PXCT, which contained this extra sequence, was negative.
Mapping of Binding Sites for AP-2 and Clathrin in SNX9 Low
Complexity Region-Investigation of the fine specificity of ␣-appendage and clathrin binding to the LC region is shown in Fig. 2 , C and D. The appendages of AP-2 are known to bind DPF and DPW sequences in various proteins (25) . Since SNX9 contains a DPW motif at amino acids 106 -108, we expected this sequence to be involved in the binding of AP-2. As can be seen in Fig. 2C , some binding of purified ␣-appendage to LC1 and LC2 containing the DPW sequence was found. However, a stronger binding was revealed when the fusion protein was extended to amino acid 183 (LC). The extra region consists of 64 amino acids containing the acidic sequence DDDDWD-EDWD. This sequence has properties reminiscent of a recently FIG. 1. Domain organization of SNX9 and description of recombinant constructs used in the present investigation. A, SNX9 contains an SH3 domain at the amino terminus followed by a region with predicted low complexity, a PX domain in the middle, and a large domain at the carboxyl terminus with predicted ␣-helical structure (CT). Recombinant proteins were expressed as GST or FLAG fusion proteins (both tags located at the amino terminus) or as untagged protein as indicated in the text and figures. B, amino acids of the part of the low complexity sequence designated LC in A. LC and sections thereof (designated LC-1, LC-2, LC-3, and LC-4) were expressed as GST fusion proteins. Tryptophan residues mutated to serines in certain constructs are highlighted (constructs LC-S108, LC-S165/S169, and LC-S108/S165/S169).
described additional motif for ␣-appendage binding (FXDXF) (26) . Indeed LC3, which contains the acidic sequence but not the DPW sequence, displayed approximately the same binding strength as LC1 and LC2. That the two described motifs are of importance was shown by the markedly weakened binding for the ␣-appendage in point mutants of LC where tryptophan residues in the respective motif were changed to serines (LC-S108/S165/S169). Mutations in either motif displayed intermediate binding (LC-S108 and LC-S165/S169), indicating a cooperative binding of the ␣-appendage to the wild-type LC sequence. Surprisingly LC4, which is a shorter version of the acidic sequence-containing region, did not show any binding of the ␣-appendage. The region between the two motifs (amino acids 120 -151) may be of importance for the correct presentation of the acidic motif in the fusion protein or may contain a weak third binding site.
Purified clathrin triskelions were used to prove a direct interaction with the LC region in SNX9 and for investigation of the binding specificity (Fig. 2D) . For the binding of clathrin, an even more pronounced cooperative effect was seen. Only the full-length sequence of LC showed significant binding, and all three tryptophan mutant variants abolished detectable interaction. The nature of the motifs that is recognized by clathrin is not obvious since SNX9 does not contain a classical "clathrin box" motif as present e.g. in the ␤-chain of AP-3 (␤3 c in Fig. 2D ). However, many variants of clathrin binding sequences have been reported recently (27) . Both affected sites in SNX9 ( 107 PWSAW and 164 DWDEDW) are slightly similar to one of the clathrin-binding sequences in amphiphysin (PWDLW) (28) , and low affinity interactions of the triskelion with these sites may result in significant cooperative binding. It appears, however, that clathrin and AP-2 use overlapping binding sites in SNX9, which may have interesting implications for the arrangements in putative ternary complexes.
Characterization of a SNX9-Dyn2 Complex in Cytosol-
The affinity of SNX9 for Dyn2 produces an association between the two proteins in a native complex in cytosol. This was shown by co-immunoprecipitations from cytosol with antibodies against both Dyn2 and SNX9 (Fig. 3A) . As a control of specificity, Eps15, which is another accessory protein involved in endocytosis (14), was not detected in the SNX9-Dyn2 complex. That substantial amounts of Dyn2 are in complex with SNX9 in cytosol was indicated by the fact that Dyn2 was seen as a major band after immunoprecipitation with anti-SNX9 and staining of the gel with Coomassie Blue (Fig. 3B) . In addition, an unidentified protein at 41 kDa was specifically co-immunoprecipitated by anti-SNX9. As judged from the staining intensity of the bands, it appears that the three components of the complex are present in a 1:1:1 molar ratio. Sedimentation velocity analysis of cytosol (Fig. 3C) showed that most of SNX9 and part of Dyn2 co-migrated with a sedimentation coefficient of 14.5 S. For a globular complex this sedimentation corresponds to a molecular mass of ϳ400 kDa. Coomassie staining of sedimentation fractions after immunoprecipitation revealed that also the 41-kDa protein co-migrated with SNX9 and Dyn2 (data not shown). Taken together, the data are most consistent with the presence of a complex consisting of two molecules each of SNX9 (78 kDa), Dyn2 (100 kDa), and p41.
SNX9 Is Assembled on Membranes-In our previous study (9) we found by cell fractionation experiments that most of SNX9 was present in the cytosol fraction with very small amounts on the membranes. We have now found that the FIG. 3 . SNX9 is associated with Dyn2 in the cytosol. A and B, co-immunoprecipitation. A, cytosol was immunoprecipitated with preimmune serum (preimmune) and anti-SNX9, anti-Dyn2, and anti-Eps15 sera. Bound proteins were analyzed by SDS-PAGE combined with immunoblotting using anti-Eps15, anti-Dyn2, and anti-SNX9 antibodies. B, cytosol was immunoprecipitated with preimmune and anti-SNX9 sera, and bound proteins were visualized by Coomassie Blue staining after SDS-PAGE. The major bands specifically immunoprecipitated are indicated. C, sedimentation velocity centrifugation of cytosol. Fractions (collected from the top) were either analyzed directly (total protein) or after immunoprecipitation with anti-SNX9 (bound and unbound) by immunoblotting with anti-Dyn2 and anti-SNX9. Sedimentation markers bovine serum albumin (66 kDa, 4.3 S), catalase (248 kDa, 11.3 S), and ferritin (467 kDa, 17.6 S) were run in a parallel gradient. membrane association of SNX9 is highly dependent on the salt concentration in the extraction buffer. If cell fractionation is performed at a physiological salt concentration, as done in the present study, at least half of SNX9 remains membrane-bound. Fig. 4A shows an experiment where the material released from the cells after a quick freeze/thaw cycle was analyzed by sedimentation and extraction. All molecules detected, including SNX9, were enriched in the membrane pellet fraction. Extraction of the pellet with detergent solubilized a large part of the total proteins but not any of the analyzed proteins. This indicates that clathrin, AP-2 (which for technical reasons was detected with an antibody that in addition recognizes AP-1), Dyn2, and SNX9 are assembled into larger, detergent-resistant complexes. However, all four molecules were efficiently extracted either by lowering the salt concentration in the buffer or by using a high concentration of Tris.
Density equilibrium centrifugation of membranes in Nycodenz (Fig. 4B) showed that clathrin and AP-2 banded at a density of ϳ1.17 g/ml, whereas Dyn2 was present on slightly lighter membranes (peak at 1.13 g/ml). SNX9 gave a broader appearance in the gradient, covering the positions of both clathrin/AP-2 and at least part of Dyn2. It may be envisioned that SNX9 is distributed into different pools at the membrane, either co-localizing with Dyn2, with AP-2, or with both. It is likely that the material analyzed contained both fragments from the plasma membrane (and possibly also intracellular membranes) together with various transport vesicles. The behavior of clathrin and AP-2 in both experiments shown in Fig.   4 is consistent with their presence on clathrin-coated pits and vesicles.
Binding of SNX9 to Liposomes-To investigate whether SNX9 has lipid binding activity on its own, we analyzed the binding of recombinant full-length SNX9 and different parts of SNX9 to artificially prepared liposomes. When tested for binding of GST-SNX9 to liposomes of different compositions, we found SNX9 to be promiscuous in its specificity (Fig. 5, A and  B) . SNX9 bound to all phosphoinositides in the tested set, and no statistically significant difference in binding was found. It is clear, however, that SNX9 requires at least one exposed phosphorous group for binding since phosphatidylinositol was negative.
The most plausible region responsible for the interaction with membranes is the PX domain. When different parts of SNX9 were assayed for liposome binding, only PX domaincontaining constructs were positive for binding (Fig. 5C ). The experiment in Fig. 5C also shows that co-sedimentation of positive fusion proteins is not due to liposome-induced aggregation and precipitation since GST-SNX9 and GST-PXCT floated together with the liposomes in high density medium by ultracentrifugation. So far, we have not been able to produce the PX domain alone in an active form. We can therefore not exclude the possibility that the CT domain influences the lipid binding or folding of the PX domain.
Localization of SNX9 in HeLa Cells-Since SNX9 interacts both with membranes and with proteins that constitute the core of the endocytic machinery, it was of importance to inves- FIG. 4 . A large part of SNX9 in the cell is associated with membranes. K562 cells were opened by a freeze/thaw cycle, and released material was separated from the rest of the cells by a low speed centrifugation. A, the supernatant was centrifuged at 70,000 ϫ g for 30 min to obtain a cytosol fraction (cytosol) and a pellet (70,000 ϫ g pellet). The pellet was washed in extraction buffer containing 0.5% Nonidet P-40 and again centrifuged. The supernatant was saved (NP40 wash), and the pellet was divided into two aliquots that were washed in a low ionic strength buffer (low salt wash) and with 0.5 M Tris-HCl (Tris wash), respectively, and the supernatants were analyzed after centrifugation. The distribution of the total protein amount in the fractions are indicated, and 10 g of each fraction were analyzed by SDS-PAGE combined with immunoblotting with antibodies against clathrin heavy chain, ␤-chains of AP-1 and AP-2 (a-␤1/␤2), Dyn2, and SNX9. B, a 70,000 ϫ g pellet fraction prepared as in A was subjected to equilibrium centrifugation in Nycodenz. Fractions were collected from the top and analyzed for clathrin, AP-2 (a-␣), Dyn2, and SNX9 by SDS-PAGE and immunoblotting. The density (dashed line) and protein content (solid line) of the fractions are shown.
tigate whether co-localization could be detected with these proteins. Immunofluorescence studies were preformed with HeLa cells that are more amenable to microscopic analysis than K562 cells (Fig. 6) . By confocal microscopy, endogenous SNX9 displayed numerous small spots in a focal plane at, or close to, the surface of the cell adhering to the glass (i.e. the plasma membrane, see Fig. 6, second and fourth rows) . In this plane, extensive co-localization was revealed with both AP-2 and Dyn2. Quantitation by dot counting showed that 72 Ϯ 12% (S.D.) and 73 Ϯ 13% (S.D.) of the SNX9-positive dots co-localized with AP-2 and Dyn2, respectively. However, a smaller fraction of the AP-2-and Dyn2-positive structures were positive for SNX9 (35 Ϯ 10% (S.D.) and 37 Ϯ 10% (S.D.), respectively), indicating the presence of different types of assemblies at the plasma membrane. At present, we cannot rule out the existence of SNX9-positive structures that are negative for both AP-2 and Dyn2. SNX9 showed no sign of co-localization with AP-1 at the trans-Golgi network, with EEA1 at early endosomes (Fig. 6) , or with Lamp-1 at lysosomes and late endosomes (data not shown). Note that for the visualization of AP-1 and EEA1, the focal plane was adjusted for optimal detection of the respective antigen, and in these areas fewer SNX9-positive spots were found.
Inhibition of Endocytosis by Overexpression of Truncated SNX9 -The ability of SNX9 to associate with several endocytic proteins (AP-2, clathrin, and Dyn2) in vivo and in vitro argues strongly for a role of this protein in endocytosis. To test this in different cell types, we moderately overexpressed (10 -15-fold) full-length and truncation variants of SNX9 in K562 cells (Fig.  7A ) and HeLa cells (Fig. 7B) and assayed for the effect on uptake of transferrin. Whereas full-length SNX9 had no detectable effect, truncations from the carboxyl terminus (SH3LCPX and SH3LC) abolished the uptake of transferrin. In contrast, expression of SNX9 with a truncation from the amino terminus (PXCT) resulted in no or very minor effect. The result from immunofluorescence analysis was confirmed by quantitation of transferrin uptake in K562 cells transfected with two of the constructs by a biochemical assay (Fig. 7C) . Control cells showed a fast uptake of transferrin and reached a plateau after 4 min of incubation (Fig. 7C, left panel) . The results for transfectants incubated for 2 min (Fig. 7C, right panel) showed that the rate of endocytosis is affected similarly as found by immunofluorescence. In conclusion, expression of truncated variants containing the binding sites for AP-2, clathrin, and Dyn2, but not full-length SNX9 containing the same sites, interfered with the endocytic process. Taken together, the results establish SNX9 as a molecule that participates in the clathrin-mediated endocytosis in cells.
DISCUSSION
The present study describes SNX9 as a molecule that in several respects differs from other sorting nexin family members. SNX9 appears to have its main role at the plasma membrane and not on endosomes, and it interacts with the core components of the endocytic machinery (i.e. clathrin, AP-2, and Dyn2) and co-localizes with both AP-2 and Dyn2. In addition, its PX domain seems to comprise different lipid specificity than those of several other investigated SNXs, which, consistent with their role at the endosomal membrane, generally have a preference for phosphatidylinositol 3-phosphate (1, 29) . FIG. 5 . Binding of SNX9 to liposomes. A and B, liposome preparations contained 50% phosphatidylcholine and either 50% phosphatidylethanolamine (denoted PE), 50% phosphatidylinositol (denoted PI), 50% phosphatidylserine (denoted PS), 40% phosphatidylinositol ϩ 10% phosphatidylinositol 3-phosphate (denoted PI(3)P), 40% phosphatidylinositol ϩ 10% phosphatidylinositol 3,4-diphosphate (denoted PI(3,4)P 2 ), 40% phosphatidylinositol ϩ 10% phosphatidylinositol 4,5-diphosphate (denoted PI(4,5)P 2 ), or 40% phosphatidylinositol ϩ 10% phosphatidylinositol 3,4,5-triphosphate (denoted PI (3, 4, 5 )P 3 ). Liposomes were incubated for 15 min on ice with 1 g of GST-SNX9. After centrifugation, the supernatants were saved (S), and the pellets (P) were washed once before analysis by SDS-PAGE and Coomassie Blue staining (A). B, the amount of GST-SNX9 in each lane was measured by densitometry, and the percentage bound was calculated. The bars show the means from three separate experiments, and the S.D. is indicated. C, liposomes consisting of 50% phosphatidylcholine, 40% phosphatidylinositol, and 5% each of phosphatidylinositol 3-phosphate and phosphatidylinositol 4,5-diphosphate were incubated with 250 ng of the indicated fusion proteins and centrifuged as in A. The supernatants were saved (Supernatant), and after washing, the liposome pellets were adjusted to 40% sucrose in HKM buffer and overlaid with equal volumes of 30% sucrose in HKM buffer and KSHM buffer. After centrifugation at 100,000 ϫ g for 1 h, the upper interphase was saved (Interphase), and the pellet was resuspended in the lower phase (Pellet). Equal parts of each saved fraction were analyzed by SDS-PAGE and immunoblotting using anti-GST antibodies. BSA, bovine serum albumin. An important discovery in this study was the presence in the cytosol of a complex between SNX9 and dynamin, a complex that also contained a third protein of 41 kDa. It appears that Dyn2 is in excess over SNX9 in the cell since in sedimentation analysis a substantial fraction of Dyn2 migrated to the bottom of the tube as larger assemblies, whereas the majority of SNX9 co-migrated with Dyn2 in the gradient (see Fig. 3C ). However, we have found that the complex is labile and rapidly dissociates if the cytosol is diluted in extraction buffer. Lowering of the salt concentration in cytosol stabilizes the complex to some extent (as done in the sedimentation and immunoprecipitation analyses), but the relative amounts of SNX9 and Dyn2 that are associated in the complex are difficult to determine for this reason. From different experiments, we estimate that at least 25% of Dyn2 is associated with SNX9. 2 Work is underway to identify the third component and to establish the role of the complex.
It is likely that SNX9 recycles between a cytosolic and a membrane-bound pool, similar to clathrin, AP-2, and dynamin. From membrane analysis and co-localization experiments we conclude that, at steady state, a large fraction of SNX9 resides at the plasma membrane or on vesicles derived from it. Dyn2 may be recruited together with SNX9 to the plasma membrane through interactions between the PX domain and membrane lipids, and the two molecules could subsequently assemble with clathrin and AP-2. SNX9 may stay together with AP-2 and clathrin after formation of the vesicle, whereas Dyn2 is released (15, 16) . In agreement with this view, a recent study showed a high enrichment of SNX9 in a purified preparation of clathrin-coated vesicles (30) .
The finding that the binding of clathrin and the ␣-appendage of AP-2 to the low complexity region of SNX9 is impeded in the full-length molecule implies that the exposure of this region in SNX9 may be regulated. Accordingly SNX9 complexes in the cytosol contain no or very little AP-2 or clathrin ( Fig. 3B and data not shown). The interaction with these molecules may be regulated to occur only at sites of macromolecular assembly. Similarly the interaction of SNX9 with the membrane may be enhanced after activation of the molecule. Taken together, cytosolic SNX9 appears to mask several of its binding regions in the resting state.
The precise role of SNX9 in the endocytic process cannot be defined at present and must await further studies. The effect of expressing truncated forms of SNX9 on the uptake of transferrin may have several possible explanations. As SNX9 has affinity for Dyn2, clathrin, and AP-2, all of which have critical roles in endocytosis, depletion of any of these molecules from the cytosol is anticipated to have a dramatic effect on the uptake of cargo. However, full-length SNX9, which appears to have the same capacity to bind Dyn2 as the SH3-containing truncated variants, does not inhibit endocytosis. This fact, together with the observation that Dyn2 appears to be in excess over SNX9, speaks against the depletion of Dyn2. On the other hand, since full-length SNX9 has its binding sites for clathrin and AP-2 masked, it is possible that variants expressed with those sites exposed may bind to both clathrin and AP-2 in the cytosol. These possible associations, which normally should occur only at the membrane, could lead to malfunction or mislocalization of clathrin and AP-2. It is also possible that for SNX9 to be functional in endocytosis, it requires the ␣-helixrich carboxyl-terminal domain. Homology searches in data bases reveal that this domain is only found in SNX9 and SNX18, and the function is so far completely unknown. The last 28 amino acids show a high probability for coiled-coil formation, and it is possible that this part is essential for the assembly of a functional multimeric complex of SNX9.
Since SNX9 is present in a complex with Dyn2 in the cytosol, SNX9 may come into play at the later stages of vesicle formation together with dynamin. It is intriguing that in addition dynamin is suggested to be involved in cellular processes not directly associated with its established role for severing nascent endocytic pits (31) . Increasing evidence suggests that dynamin participates in the nucleation of actin filaments, both at the sites of endocytosis and elsewhere (32, 33) . It is anticipated that dynamin, together with SH3 domain-containing proteins, is part of a regulatory machinery for formation of cross-linked actin meshworks by the Arp2/3 complex. Several SH3-containing proteins are suggested to link dynamin to distinct sites of actin nucleation, including Grb2, syndapin, Abp1, intersectin, and cortactin. SNX9 may be involved in this system since we show here that significant amounts of endogenous dynamin in the cytosol are indeed in a complex with SNX9. Furthermore studies have shown that SNX9 through its SH3 domain can bind to Wiskott-Aldrich syndrome protein (WASP) (6), 2 which is a major regulator of actin polymerization via Arp2/3. It is possible that SNX9 in addition is involved in cellular functions apart from, or in conjunction with, the endocytic process focused upon in the present study.
